58 results on '"Horiuchi, Masatsugu"'
Search Results
2. Interferon regulatory factor 1 attenuates vascular remodeling; roles of angiotensin II type 2 receptor
3. Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia
4. Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on prevention of cognitive decline in type 2 diabetic mice
5. Role of renin–angiotensin–aldosterone system in adipose tissue dysfunction
6. ACE2 deficiency induced perivascular fibrosis and cardiac hypertrophy during postnatal development in mice
7. Reciprocal regulation of cholesterol excretion in apolipoprotein E-null mice by angiotensin II type 1 and type 2 receptor deficiency
8. Inhibition of MCP-1/CCR2 signaling pathway is involved in synergistic inhibitory effects of irbesartan with rosuvastatin on vascular remodeling
9. Influence of angiotensin II type 1 receptor-associated protein on prenatal development and adult hypertension after maternal dietary protein restriction during pregnancy
10. Angiotensin II type 2 receptor-interacting protein prevents vascular senescence
11. Corrigendum to “Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: Evidence from vascular-targeted transgenic mice of AT2 receptor” [Biochem. Biophys. Res. Commun. 282 (2001) 1085–1091]
12. Irbesartan attenuates ischemic brain damage by inhibition of MCP-1/CCR2 signaling pathway beyond AT1 receptor blockade
13. Irbesartan increased PPARγ activity in vivo in white adipose tissue of atherosclerotic mice and improved adipose tissue dysfunction
14. Possible involvement of AT2 receptor dysfunction in age-related gender difference in vascular remodeling
15. Unique “delta lock” structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1 receptor
16. Female type 2 diabetes mellitus mice exhibit severe ischemic brain damage
17. Female exhibited severe cognitive impairment in type 2 diabetes mellitus mice
18. Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway
19. Timp-3 deficiency impairs cognitive function in mice
20. Sex-different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function
21. Signaling mechanisms of angiotensin II in regulating vascular senescence
22. Telmisartan prevented cognitive decline partly due to PPAR-γ activation
23. Hypotensive activity of novokinin, a potent analogue of ovokinin(2–7), is mediated by angiotensin AT2 receptor and prostaglandin IP receptor
24. Inhibition of cognitive decline in mice fed a high-salt and cholesterol diet by the angiotensin receptor blocker, olmesartan
25. Upregulation of the ligand–RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis
26. Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model
27. AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling
28. A Possible Anti-Inflammatory Role of Angiotensin II Type 2 Receptor in Immune-Mediated Glomerulonephritis during Type 1 Receptor Blockade
29. AT1 Receptor Associated Protein
30. Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress
31. Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis
32. A Novel Function of Angiotensin II in Skin Wound Healing
33. Roles of AT1 and AT2 Receptors in Atherogenesis
34. Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia
35. Nuclear receptor LXRα is involved in cAMP-mediated human renin gene expression
36. Trans-inactivation of Receptor Tyrosine Kinases by Novel Angiotensin II AT2 Receptor-interacting Protein, ATIP
37. Intracellular third loops in AT1 and AT2 receptors determine subtype specificity
38. Effect of Angiotensin II Type 2 Receptor on Tyrosine Kinase Pyk2 and c-Jun NH2-Terminal Kinase via SHP-1 Tyrosine Phosphatase Activity: Evidence from Vascular-Targeted Transgenic Mice of AT2 Receptor
39. ATRAP, Novel AT1 Receptor Associated Protein, Enhances Internalization of AT1 Receptor and Inhibits Vascular Smooth Muscle Cell Growth
40. Molecular Mechanism of Fibronectin Gene Activation by Cyclic Stretch in Vascular Smooth Muscle Cells
41. Aggravation of chemically-induced injury in perfused rat liver by extracellular ATP
42. Signaling Mechanism of the AT2 Angiotensin II Receptor: Crosstalk between AT1 and AT2 Receptors in Cell Growth
43. Increased Vasoconstrictor Response of the Mouse Lacking Angiotensin II Type 2 Receptor
44. Activation of the de novo Biosynthesis of Sphingolipids Mediates Angiotensin II Type 2 Receptor-induced Apoptosis
45. Cloning and Characterization of ATRAP, a Novel Protein That Interacts with the Angiotensin II Type 1 Receptor
46. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: An in vitro gene transfer study
47. Mechanism of Angiotensin II-mediated Regulation of Fibronectin Gene in Rat Vascular Smooth Muscle Cells
48. Vascular Remodeling—The Emerging Paradigm of Programmed Cell Death (Apoptosis)
49. Role of AP-1 Complex in Angiotensin II-Mediated Transforming Growth Factor-β Expression and Growth of Smooth Muscle Cells: Using Decoy Approach against AP-1 Binding Site
50. Angiotensin Type 2 Receptor Dephosphorylates Bcl-2 by Activating Mitogen-activated Protein Kinase Phosphatase-1 and Induces Apoptosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.